COVID-19 infected people are being treated by healthcare specialists all over the world. Diabetes has a deleterious effect on the prognosis of COVID-19 patients. Both hyper and hypoglycemia in hospitalised patients might predict negative outcomes; additionally, it causes chronic inflammation and numerous organ damage, which promotes oxidative stress and the release of inflammatory mediators. To lessen the severity of disease in diabetic individuals infected with COVID-19, glycemic management must be optimised. The impact of HbA1c on mortality in COVID-19 and T2DM patients is unknown. As a result, the current study focused on the relationship between HbA1c levels and COVID-19 severity in T2DM patients.
Author (S) Details
Balaji Vijayam
Dr. V Balaji Dr. V Seshiah Diabetes Care and Research Institute, Chennai, Tamil Nadu, India.
Madhuri S. Balaji
Dr. V Balaji Dr. V Seshiah Diabetes Care and Research Institute, Chennai, Tamil Nadu, India.
Taarika Balaji
Saveetha Institute of Technical and Medical Sciences, Chennai, Tamil Nadu, India.
Seshiah Veerasamy
Dr. V Balaji Dr. V Seshiah Diabetes Care and Research Institute, Chennai, Tamil Nadu, India.
A. Anitha Rani
Dr. V Balaji Dr. V Seshiah Diabetes Care and Research Institute, Chennai, Tamil Nadu, India.
Shalini Devaraj
Dr. V Balaji Dr. V Seshiah Diabetes Care and Research Institute, Chennai, Tamil Nadu, India.
View Book :- https://stm.bookpi.org/RDMMR-V5/article/view/4212
